FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Novartis AG Hires Bank of America to Officially Review Alcon Options April 20, 2017 Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug May 7, 2017 Google's Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics March 23, 2017
